Consolidated Statements of Financial Condition - USD ($) $ in Thousands		Mar. 31, 2017	Mar. 31, 2016		Mar. 31, 2015
Cash and cash equivalents:
Cash and due from banks		$ 58,428	$ 62,684	[1],[2]
Money market investments		258	504	[1],[3]
Total cash and cash equivalents		58,686	63,188	[1],[3],[4],[5]	$ 50,824	[4],[5]
Restricted cash		283	225	[1],[3]
Investment securities:
Available-for-sale Securities		59,011	56,180	[1]
Held-to-maturity	[6]	13,435	15,311	[1],[4]
Total investment securities		72,446	71,491	[1],[4]
Loans held-for-sale (HFS)		944	2,436	[1],[7]
Loans receivable:
Real estate mortgage loans		471,444	517,633	[1],[2]
Commercial business loans		65,114	70,953	[1]
Consumer loans		8,994	42	[1]
Loans, gross		545,552	588,628	[1],[2]
Allowance for loan losses		(5,060)	(5,232)	[1]	(4,428)
Total loans receivable, net		540,492	583,396	[1],[8]
Premises and equipment, net		5,427	5,983	[1]
Federal Home Loan Bank of New York (“FHLB-NY”) stock, at cost		2,171	2,883	[1]
Accrued interest receivable		1,583	2,420	[1]
Other assets		5,829	7,032	[1]
Total assets		687,861	739,054	[1]
Deposits:
Savings		100,913	95,230	[1]
Non-interest bearing checking		61,576	56,634	[1]
Interest-bearing checking		37,180	33,106	[1]
Money market		140,807	163,380	[1]
Certificates of deposit		236,342	255,854	[1]
Escrow		2,358	2,537	[1]
Total deposits		579,176	606,741	[1]
Advances from the FHLB-NY and other borrowed money		49,403	68,403	[1]
Other liabilities		11,884	12,030	[1],[2]
Total liabilities		640,463	687,174	[1]
EQUITY
Preferred stock		45,118	45,118	[1],[4]
Common stock		61	61	[1],[4]
Additional paid-in capital		55,474	55,470	[1],[4]
Accumulated deficit		(50,898)	(48,045)	[2],[4]
Treasury Stock, at cost		(417)	(417)	[1],[4]
Accumulated other comprehensive loss		(1,940)	(307)	[1],[4]
Total equity		47,398	51,880	[2],[4],[9]	$ 52,907	[3]
Total liabilities and equity		$ 687,861	$ 739,054	[2],[4]

[1] (1) March 31, 2016 balances have been restated from previously reported results to correct for material and certain other errors from prior periods. Equity in net loss from subsidiaries was increased and total income was reduced by $1.5 million, interest expense on borrowings and total expense were increased by $66 thousand, and net loss and comprehensive loss were increased $1.6 million. Refer to Notes 1 and 19 for further detail.

[2] (1) March 31, 2016 balances have been restated from previously reported results to correct for material and certain other errors from prior periods. Refer to Notes 1 and 19 for further detail.

[3] (1) March 31, 2016 balances have been restated from previously reported results to correct for material and certain other errors from prior periods. Refer to Notes 1 and 19 for further detail.

[4] (1) March 31, 2015 and 2016 balances have been restated from previously reported results to correct for material and certain other errors from prior periods. Refer to Notes 1 and 19 for further detail.

[5] (1) March 31, 2016 balances have been restated from previously reported results to correct for material and certain other errors from prior periods. Net loss was increased by $1.6 million, equity in net loss of subsidiaries was increased by $1.5 million and increase in other liabilities was increased by $66 thousand. Refer to Notes 1 and 19 for further detail.

[6] * The carrying amount and amortized cost are the same for all held-to-maturity securities, as no OTTI has been recorded.

[7] (1) March 31, 2016 balances have been restated from previously reported results to correct for material and certain other errors from prior periods. Investment in subsidiaries, total assets and total liabilities and stockholders' equity were each reduced by $2.2 million, other liabilities and total liabilities increased by $157 thousand and stockholders' equity was reduced by $2.3 million. Refer to Notes 1 and 19 for further detail.

[8] (1) March 31, 2016 balances have been restated from previously reported results to correct for material and certain other errors from prior periods. Refer to Notes 1 and 19 for further detail.

[9] (1) March 31, 2016 balances have been restated from previously reported results to correct for material and certain other errors from prior periods. Refer to Notes 1 and 19 for further detail.